Literature DB >> 16889745

Development and validation of a platelet calcium flux assay using a fluorescent imaging plate reader.

Eddie C-K Liu1, Lynn M Abell.   

Abstract

Calcium signaling in platelets is an important physiological response to various aggregation stimuli. Loading platelets with various fluorescent dyes and measuring the change in calcium concentration using a spectrofluorometer has been the traditional approach to studying calcium signaling. This method suffers from the need for large platelet samples and a decrease in total fluorescence signal with time due to photobleaching. Therefore, it is rarely used to measure the quantitative effect of an agonist or antagonist on calcium signaling. Adaptation of these measurements to a fluorescent imaging plate reader (FLIPR) format allows the sample size to be reduced by 5- to 10-fold, and the microplate format allows a significant increase in throughput. Addition of the agonists to all wells simultaneously serves to normalize the total response. This article describes the first use of a FLIPR to study the calcium flux in human platelets. The IC(50) values showed a linear correlation with the K(i) for receptor binding in washed platelets. The generality of the methodology was shown by measuring EC(50) values for agonists and IC(50) values for antagonists of the platelet G protein-coupled receptor P2Y(1) and for the ion channel P2X(1).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16889745     DOI: 10.1016/j.ab.2006.06.034

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  8 in total

1.  Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y₁₂ receptor-mediated platelet aggregation.

Authors:  Carl Högberg; Olof Gidlöf; Francesca Deflorian; Kenneth A Jacobson; Aliaa Abdelrahman; Christa E Müller; Björn Olde; David Erlinge
Journal:  Thromb Haemost       Date:  2012-05-25       Impact factor: 5.249

2.  Lead compound design for TPR/COX dual inhibition.

Authors:  Abhay Krishna; Arpita Yadav
Journal:  J Mol Model       Date:  2012-05-16       Impact factor: 1.810

3.  Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates.

Authors:  Christian C Yost; Mark J Cody; Estelle S Harris; Nathan L Thornton; Alison M McInturff; Mark L Martinez; Nancy B Chandler; Christopher K Rodesch; Kurt H Albertine; Cathy A Petti; Andrew S Weyrich; Guy A Zimmerman
Journal:  Blood       Date:  2009-02-12       Impact factor: 22.113

4.  Expression and function of purinergic receptors in platelets from apheresis-derived platelet concentrates.

Authors:  Juergen Koessler; Katja Weber; Angela Koessler; Pinar Yilmaz; Markus Boeck; Anna Kobsar
Journal:  Blood Transfus       Date:  2015-11-17       Impact factor: 3.443

Review 5.  Terminal Phenoxy Group as a Privileged Moiety of the Drug Scaffold-A Short Review of Most Recent Studies 2013-2022.

Authors:  Paweł Kozyra; Monika Pitucha
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

6.  Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay.

Authors:  Marie Lordkipanidzé; Gillian C Lowe; Nicholas S Kirkby; Melissa V Chan; Martina H Lundberg; Neil V Morgan; Danai Bem; Shaista P Nisar; Vincenzo C Leo; Matthew L Jones; Stuart J Mundell; Martina E Daly; Andrew D Mumford; Timothy D Warner; Steve P Watson
Journal:  Blood       Date:  2014-01-09       Impact factor: 22.113

7.  Role of Purinergic Receptor Expression and Function for Reduced Responsiveness to Adenosine Diphosphate in Washed Human Platelets.

Authors:  Juergen Koessler; Stephanie Hermann; Katja Weber; Angela Koessler; Sabine Kuhn; Markus Boeck; Anna Kobsar
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

8.  The role of adenosine diphosphate mediated platelet responsiveness for the stability of platelet integrity in citrated whole blood under ex vivo conditions.

Authors:  Juergen Koessler; Michaela Schwarz; Katja Weber; Julia Etzel; Angela Koessler; Markus Boeck; Anna Kobsar
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.